Prima Biomed Ltd
ASX:PRR ISIN:AU000000PRR9
Prima Biomed (ASX:PRR) is a biotechnology company based in Sydney, Australia. The Company is focused on technologies in the fields of immunology and cancer immunotherapy. Prima is focused on developing a dendritic-cell based immunotherapy targeting mucin-1 tumour expressed antigen. Prima's lead product, CVac(tm) has completed Phase IIa clinical development in Ovarian Cancer and is working to a path of US FDA IND approval.
Lihat di Bahasa Lain
Berita
Laporan Pasar Australia 21 Februari 2011 memuat: Prima BioMed (ASX:PRR) akan memulai Tahap III uji coba klinis bagi vaksin imunoterapi kanker; Redstone Resources Limited (ASX:RDS) mengumumkan hasil tembaga bermutu tinggi di Proyek Tembaga Tollu di Australia Barat; Western Desert Resources Limited (ASX:WDR) melaporkan hasil biji besi bermutu tinggi di Proyek Biji Besi Roper Bar di Northern Territory; Canyon Resources Limited (ASX:CAY) memperbaharui percepatan program penggalian di Burkina Faso.
###
139,610 TAMPILAN PROFIL PERUSAHAAN
- Halaman ini dilihat: (7 Hari Terakhir: 11) (30 Hari Terakhir: 47) (Sejak Ditampilkan: 10746)
